Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Medtronic
Baxter
McKinsey
Express Scripts

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

ALVESCO Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Alvesco patents expire, and when can generic versions of Alvesco launch?

Alvesco is a drug marketed by Covis Pharma Bv and is included in one NDA. There is one patent protecting this drug.

This drug has thirteen patent family members in eleven countries.

The generic ingredient in ALVESCO is ciclesonide. There are seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ciclesonide profile page.

Drug patent expirations by year for ALVESCO
Drug Prices for ALVESCO

See drug prices for ALVESCO

Recent Clinical Trials for ALVESCO

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
West Penn Allegheny Health SystemPhase 4
AstraZenecaN/A
Nottingham University Hospitals NHS TrustPhase 4

See all ALVESCO clinical trials

Synonyms for ALVESCO
(11?,16?)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy)-pregna-1,4-diene-3,20-dione
(11?,16?)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy)pregna-1,4-diene-3,20-dione
(11|A,16|A)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy)-pregna-1,4-diene-3,20-dione
(R)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde, 21-isobutyrate
126544-47-6
141845-82-1
2-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-cyclohexyl-7-hydroxy-6a,8a-dimethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-
2-oxoethyl isobutyrate
2H-Naphth (2',1':4,5) indeno (1,2-d) (1,3) dioxole, pregna-1,4-diene-3,20-dione deriv.
544C476
AC-1330
AC1MIWNR
AKOS015994702
Alvesco (TN)
Alvesco HFA
Alvesco, Ciclesonide
AN-15021
B-9207-015
BC220461
BTR-15
BTR-15K
BY-9010
BYK-20426
C-23151
C32H44O7
CAS-141845-82-1
CC-25775
CHEBI:31397
CHEMBL2040682
Ciclesonide
Ciclesonide (JAN/USAN/INN)
Ciclesonide [INN]
Ciclesonide [USAN:INN]
Ciclesonide, >=98% (HPLC)
Ciclesonide, European Pharmacopoeia (EP) Reference Standard
CS-2867
D01703
DB01410
DSSTox_CID_26659
DSSTox_GSID_46659
DSSTox_RID_81802
DTXSID9046659
el-87-6
GTPL7469
HMS3714N07
HY-B0625
KS-1165
LS-186047
LUKZNWIVRBCLON-GXOBDPJESA-N
MolPort-005-940-705
NCGC00167484-01
NCGC00167972-01
O945
Omnair
Omnaris
Omnaris (TN)
Omnaris HFA
Osonase
Osonide
Pregna-1,4-diene-3,20-dione, 16,17-(((R)-cyclohexylmethylene)bis(oxy))-11-hydroxy-21-(2-methyl-1-oxopropoxy)-, (11beta,16alpha)-
Pregna-1,4-diene-3,20-dione, 16,17-((cyclohexylmethylene)bis(oxy))-11-hydroxy-21-(2-methyl-1-oxopropoxy)-, (11beta,16alpha(R))-
RPR 251526
RPR-251526
RPR251526
s4646
S59502J185
SCHEMBL3688
SR-01000942227
SR-01000942227-1
TBN-15
Tox21_112486
UNII-S59502J185
Zetonna
ZINC3915154

US Patents and Regulatory Information for ALVESCO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Covis Pharma Bv ALVESCO ciclesonide AEROSOL, METERED;INHALATION 021658-002 Jan 10, 2008 RX Yes Yes   See Pricing   See Pricing   See Pricing
Covis Pharma Bv ALVESCO ciclesonide AEROSOL, METERED;INHALATION 021658-003 Jan 10, 2008 RX Yes Yes   See Pricing   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ALVESCO

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Covis Pharma Bv ALVESCO ciclesonide AEROSOL, METERED;INHALATION 021658-002 Jan 10, 2008   See Pricing   See Pricing
Covis Pharma Bv ALVESCO ciclesonide AEROSOL, METERED;INHALATION 021658-003 Jan 10, 2008   See Pricing   See Pricing
Covis Pharma Bv ALVESCO ciclesonide AEROSOL, METERED;INHALATION 021658-003 Jan 10, 2008   See Pricing   See Pricing
Covis Pharma Bv ALVESCO ciclesonide AEROSOL, METERED;INHALATION 021658-003 Jan 10, 2008   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Medtronic
Colorcon
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.